The Immunohistochemistry (IHC) market size was valued at USD 1.9 billion in 2021 and is poised to grow at a significant CAGR of 9.2% during the forecast period 2022–2028. In the future, the market will be expected to grow due to the rise in the prevalence of chronic diseases. The increase in patients with cancer, infectious diseases, and cardiovascular disorders where immunohistochemistry is employed for diagnosis would aid the industry's expansion and help it capture its market share shortly. The rate at which infectious diseases are growing is worrying, which challenges medical professionals in creating drugs for such unidentified diseases. The rise in demand for treating such conditions will soon propel the market to a flourishing pace.

 View Detailed Report Description Here - https://precisionbusinessinsights.com/market-reports/global-immunohistochemistry-market/

 

The global Immunohistochemistry (IHC) market is segmentation:  

1) By Product: Antibodies (Primary antibodies and Secondary antibodies.

2) Reagents: Histological Stains, Blocking Sera and Reagents, Chromogenic Substrates, Fixation Reagents, Organic Solvents, Proteolytic Enzymes, Diluents, Other Reagents.

3) Equipment: Slide-staining Systems, Tissue Processing Systems, Slide Scanners, Other Equipment.

4) Kits: IHC Kits for Human tissue, IHC Kits for Animal tissue.

5) by Application: Diagnostic applications (Cancer, Infectious diseases, Autoimmune diseases, Nephrological diseases, Neurological diseases, other diseases) Research Applications (Drug development and Testing, Other research applications), Forensic applications.

6) by End-user: Hospitals & Diagnostic Laboratories, Academic & research Institutes, Other end users.

Diagnostic Applications Segment to Dominate the Immunohistochemistry (IHC) Market

The diagnostic applications segment is expected to account for a larger revenue share in the global Immunohistochemistry (IHC) market, with a value share worldwide. It is projected to grow at a 10.2% CAGR between 2022 and 2028. The growing prevalence of cancer and the widespread use of immunohistochemistry in diagnosing infectious diseases, cardiovascular disorders, and other diseases are credited with the high proportion of this market. Lung, female breast, bowel, and prostate cancer are the four types of cancer that are diagnosed most frequently worldwide, according to Cancer Research UK. More than four in ten of all malignancies diagnosed worldwide are one of these four. By 2040, there will be 27.5 million new cases of cancer year, and there will be 9.6 million cancer-related deaths globally. A few other reasons driving the market expansion include an aging population that is more susceptible to infections and other chronic diseases and an increase in diagnostic facilities worldwide.

 

Asia Pacific Immunohistochemistry (IHC) Market
The Asia Pacific market is expected to increase in the global Immunohistochemistry (IHC) market over the forecast period. It is projected to grow at a CAGR of 10.4% in the coming years. Due to some factors, including rising disposable income, expanding healthcare spending, increasing demand for high-quality medical care, and rising pharmaceutical and biopharmaceutical company investments, APAC is anticipated to grow at the quickest rate over the projection period. Other significant factors influencing the growth of the immunohistochemistry market in APAC include the rising frequency of chronic diseases, the rapidly rising elderly population, increased university and government spending on diagnostic research, and numerous industry participants.

The global Immunohistochemistry (IHC) market further reveals that the key players are increasingly adopting strategies such as the launch of newer products, product launches, and long-term alliances to improve market revenue share and gain significant geographic presence across the region. For instance, In August 2021, Agilent received a CE-IVD mark in Europe for its PD-L1 IHC 22C3 pharmDx assay for the identification of oesophageal cancer patients for treatment with KEYTRUDA.

Request sample report https://precisionbusinessinsights.com/request-sample/?product_id=39848    

Key players  in the Immunohistochemistry (IHC) market report are Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Merck KGaA, Danaher Corporation, Perkinelmer, Inc., Bio-Rad Laboratories, Inc., Cell Signaling Technology, Inc., Bio SB, Agilent Technologies, Inc., and Abcam plc.

 

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

 

Contact:

Mr. Satya

Precision Business Insights | Toll Free: +1 866 598 1553

Email: sales@precisionbusinessinsights.com
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747